The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial.
Leuk Lymphoma
; 47(11): 2321-30, 2006 Nov.
Article
em En
| MEDLINE
| ID: mdl-17107904
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Linfoma não Hodgkin
/
Dexametasona
/
Idarubicina
/
Clorambucila
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article